TUCKER, Ga. — The U.S. Poultry & Egg Association and the USPOULTRY Foundation have announced the completion of a funded research project at the University of Georgia in Athens, Ga., in which researchers have developed a new vaccine candidate for infectious laryngotracheitis (ILT) to be applied in ovo.
Researchers at the University of Georgia, led by Dr. Maricarmen García in the Department of Population Health, found that deleting a gene from the ILT virus makes the virus less virulent and more useful as a vaccine.
The new vaccine gives good protection against ILT but is not safe. . .
Register or Login to keep reading
Thank you for your interest in accessing the complete content. To continue reading, please register for free. By registering, you'll gain full access to our valuable resources, updates, and insights.
If you already have an account please Log In.
